General

  Canada NewsWire BASEL, Switzerland , April 5, 2021 /CNW/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading clinical-stage

  Canada NewsWire Health Canada’s Approval of FOCLIVIA ® (An Adjuvanted, Egg-Based A Strain H5N1 Pandemic Influenza Vaccine) Meets Key

Bohemia, New York–(Newsfile Corp. – January 28, 2021) – AmpliTech Group, Inc. (OTCQB: AMPG) announced today that they have appointed

Bohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,

Regor Therapeutics Announces Completion of $90 Million Series B Financing Canada NewsWire SHANGHAI , Feb. 18, 2021 /CNW/ — Regor

  Canada NewsWire VANCOUVER, BCandHOUSTON, Feb. 17, 2021/CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage

Canada NewsWire VANCOUVER, BC andHOUSTON,Feb. 16, 2021/CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused

PAOG Targets $18 Billion Anxiety And Depression Treatment Market Sandusky, Ohio–(Newsfile Corp. – February 11, 2021) – PAO Group, Inc.

  Canada NewsWire Company Expects to Use Proceeds for Clinical Development and Commercialization Efforts TORONTO,Feb. 10, 2021/CNW/ – SQI Diagnostics Inc.

Canada NewsWire /NOT FOR DISTRIBUTION TOUNITED STATESNEWS WIRE SERVICES OR FOR DISSEMINATION INTHE UNITED STATES./ KELOWNA, BC,Jan. 25, 2021/CNW/ –